Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Nasdaq Real Time Price USD

Kenvue Inc. (KVUE)

Compare
23.98
+0.28
+(1.18%)
At close: March 31 at 4:00:02 PM EDT
23.75
-0.23
(-0.96%)
After hours: March 31 at 7:47:27 PM EDT
Loading Chart for KVUE
  • Previous Close 23.70
  • Open 23.84
  • Bid 23.50 x 3100
  • Ask 24.08 x 3200
  • Day's Range 23.62 - 24.03
  • 52 Week Range 17.67 - 24.46
  • Volume 16,359,896
  • Avg. Volume 14,965,030
  • Market Cap (intraday) 45.832B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 43.60
  • EPS (TTM) 0.55
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield 0.82 (3.46%)
  • Ex-Dividend Date Feb 12, 2025
  • 1y Target Est 24.25

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

www.kenvue.com

22,000

Full Time Employees

December 29

Fiscal Year Ends

Recent News: KVUE

View More

Performance Overview: KVUE

Trailing total returns as of 3/31/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

KVUE
13.43%
S&P 500 (^GSPC)
4.59%

1-Year Return

KVUE
16.16%
S&P 500 (^GSPC)
6.80%

3-Year Return

KVUE
6.07%
S&P 500 (^GSPC)
23.87%

5-Year Return

KVUE
6.07%
S&P 500 (^GSPC)
117.13%

Compare To: KVUE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KVUE

View More

Valuation Measures

Annual
As of 3/31/2025
  • Market Cap

    45.83B

  • Enterprise Value

    53.48B

  • Trailing P/E

    44.41

  • Forward P/E

    20.83

  • PEG Ratio (5yr expected)

    2.45

  • Price/Sales (ttm)

    2.98

  • Price/Book (mrq)

    4.74

  • Enterprise Value/Revenue

    3.46

  • Enterprise Value/EBITDA

    21.67

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.67%

  • Return on Assets (ttm)

    6.88%

  • Return on Equity (ttm)

    9.87%

  • Revenue (ttm)

    15.45B

  • Net Income Avi to Common (ttm)

    1.03B

  • Diluted EPS (ttm)

    0.55

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.07B

  • Total Debt/Equity (mrq)

    90.18%

  • Levered Free Cash Flow (ttm)

    1.62B

Research Analysis: KVUE

View More

Company Insights: KVUE

Research Reports: KVUE

View More

People Also Watch